Results 301 to 310 of about 1,212,027 (321)

Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases

Experimental Dermatology, 2007
Takashi Matsushita, Minoru Hasegawa
exaly  

SCLERODERMA (Systemic Sclerosis)

1987
E.C. HUSKISSON, F. DUDLEY HART
openaire   +2 more sources

Clinical characteristics of scleroderma overlap syndromes: comparisons with pure scleroderma

International Journal of Rheumatic Diseases, 2016
Chingching Foocharoen, Ajanee Mahakkanukrauh, Ratanavadee Nanagara   +2 more
exaly  

Scleroderma in South Australia: epidemiological observations of possible pathogenic significance

Internal Medicine Journal, 2001
P Barria
exaly  

Diagnosis and Therapy of Localized Scleroderma

JDDG - Journal of the German Society of Dermatology, 2009
Alexander Kreuter, Margitta Worm, Jörg Wenzel   +2 more
exaly  

The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: An evaluation of their measurement properties

Arthritis and Rheumatism, 2005
Sindhu R Johnson
exaly  

SYSTEMIC SCLERODERMA: A REVIEW OF ORGAN SYSTEMS

International Journal of Dermatology, 1974
Roy R. Kinder, Raul Fleischmajer
openaire   +3 more sources

Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma

Nature Clinical Practice Rheumatology, 2007
B. Deleuran, D. Abraham
semanticscholar   +1 more source

Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation

Internal Medicine Journal, 2006
Geza Benke
exaly  

Localized scleroderma

Dermatologic Therapy, 2012
Alexander Kreuter
exaly